Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies.

The effects of polyethylene glycol 20000 (PEG 20000) on the intestinal absorption of prednisolone, methylprednisolone and quinidine, three P-glycoprotein (P-gp) substrates, across the isolated rat intestinal membranes were examined by an in-vitro diffusion chamber system. The serosal-to-mucosal (secretory) transport of these P-gp substrates was greater than their mucosal-to-serosal (absorptive) transport, indicating that their net movement across the intestinal membranes was preferentially in the secretory direction. The polarized secretory transport of these drugs was remarkably diminished and their efflux ratios decreased in the presence of PEG 20000. In addition, PEG 20000 did not affect the transport of Lucifer yellow, a non-P-gp substrate. The intestinal membrane toxicity of PEG 20000 was evaluated by measuring the release of alkaline phosphatase (ALP) and protein from the intestinal membranes. The release of ALP and protein was enhanced in the presence of 20 mM sodium deoxycholate (NaDC), a positive control, while these biological parameters did not change in the presence of 0.1-5% (w/v) PEG 20000. These findings indicated that the intestinal membrane damage caused by PEG 20000 was not a main reason for the enhanced absorptive transport of these P-gp substrates in the presence of PEG 20000. Furthermore, the transepithelial electrical resistance (TEER) of rat jejunal membranes in the presence or absence of PEG 20000 was measured by a diffusion chamber method. PEG 20000 (0.1-5.0 % w/v) did not change the TEER values of the rat jejunal membranes, indicating that the increase in the absorptive transport of these P-gp substrates might not be due to the increased transport of these P-gp substrates via a paracellular pathway caused by PEG 20000. Finally, the effect of PEG 20000 on the intestinal absorption of quinidine was examined by an in-situ closed-loop method. The intestinal absorption of quinidine was significantly enhanced in the presence of 0.1-1.0% (w/v) PEG 20000. These findings suggest that PEG 20000 might be a useful excipient to improve the intestinal absorption of quinidine, which is mainly secreted by a P-gp-mediated efflux system in the intestine.

[1]  Z. Zuo,et al.  Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. , 2004, International journal of pharmaceutics.

[2]  G. Grass,et al.  In Vitro Measurement of Gastrointestinal Tissue Permeability Using a New Diffusion Cell , 1988, Pharmaceutical Research.

[3]  H. Saitoh,et al.  Possible Involvement of Multiple P-Glycoprotein-Mediated Efflux Systems in the Transport of Verapamil and Other Organic Cations Across Rat Intestine , 1995, Pharmaceutical Research.

[4]  T. Fujita,et al.  Effectiveness and Toxicity Screening of Various Absorption Enhancers in the Rat Small Intestine: Effects of Absorption Enhancers on the Intestinal Absorption of Phenol Red and the Release of Protein and Phospholipids from the Intestinal Membrane , 1996, The Journal of pharmacy and pharmacology.

[5]  Lawrence X. Yu,et al.  Evaluation of USP apparatus 3 for dissolution testing of immediate-release products , 2008, AAPS PharmSci.

[6]  D. Back,et al.  Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components. , 1999, British journal of clinical pharmacology.

[7]  D. Thakker,et al.  Efflux Ratio Cannot Assess P-Glycoprotein-Mediated Attenuation of Absorptive Transport: Asymmetric Effect of P-Glycoprotein on Absorptive and Secretory Transport Across Caco-2 Cell Monolayers , 2003, Pharmaceutical Research.

[8]  Akira Yamamoto,et al.  Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes. , 2004, Journal of pharmaceutical sciences.

[9]  T. Fujita,et al.  Improvement of intestinal absorption of insulin and water-soluble macromolecular compounds by chitosan oligomers in rats. , 2008, International journal of pharmaceutics.

[10]  R. Borchardt,et al.  Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells. , 1997, Journal of pharmaceutical sciences.

[11]  Hiroshi Saitoh,et al.  Secretory transport of methylprednisolone possibly mediated by P-glycoprotein in Caco-2 cells. , 2002, Biological & pharmaceutical bulletin.

[12]  Akira Yamamoto,et al.  Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in Rats , 1994, Pharmaceutical Research.

[13]  K. Higaki,et al.  Role of P-glycoprotein as a secretory mechanism in quinidine absorption from rat small intestine. , 1998, Journal of pharmaceutical sciences.

[14]  Christopher J. H. Porter,et al.  An in vitro examination of the impact of polyethylene glycol 400, pluronic P85, and vitamin E d-a-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine , 2002, AAPS PharmSci.

[15]  Fridrun Podczeck,et al.  Influence of Polyethylene Glycol 400 on the Gastrointestinal Absorption of Ranitidine , 2002, Pharmaceutical Research.

[16]  T. Fujita,et al.  Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu(1,7)]-eel calcitonin in rats. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Akira Yamamoto,et al.  Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats. , 2007, Biological & pharmaceutical bulletin.

[18]  James E Polli,et al.  Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[19]  Ming Yao,et al.  Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats , 2003, Archives of pharmacal research.

[20]  T. Fujita,et al.  Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane. , 1996, Biological & pharmaceutical bulletin.

[21]  P Langguth,et al.  P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. , 1998, Journal of pharmaceutical sciences.

[22]  D. Thakker,et al.  Rhodamine 123 Requires Carrier-Mediated Influx for Its Activity as a P-Glycoprotein Substrate in Caco-2 Cells , 2003, Pharmaceutical Research.

[23]  Georges Houin,et al.  Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. , 2004, International journal of pharmaceutics.

[24]  Ronald T Borchardt,et al.  A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. , 2002, Journal of pharmaceutical sciences.

[25]  M. Rowland,et al.  Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2. , 1999, The Journal of pharmacology and experimental therapeutics.

[26]  B. Hirst,et al.  Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption , 1997 .

[27]  I. Tamai,et al.  Limited influence of P-glycoprotein on small-intestinal absorption of cilostazol, a high absorptive permeability drug. , 2003, Journal of pharmaceutical sciences.

[28]  H. Vromans,et al.  Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs. , 2003, International journal of pharmaceutics.

[29]  Y Zhang,et al.  Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. , 1998, Journal of pharmaceutical sciences.

[30]  T. Fujita,et al.  Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine. , 2008, International journal of pharmaceutics.

[31]  H. Lennernäs.  Intestinal drug absorption and bioavailability: beyond involvement of single transport function , 2003, The Journal of pharmacy and pharmacology.

[32]  M. Yazdanian,et al.  Evaluation of an accelerated Caco-2 cell permeability model. , 2000, Journal of pharmaceutical sciences.

[33]  F. Hirayama,et al.  Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus. , 2001, The Journal of pharmacology and experimental therapeutics.

[34]  Thomas J. Raub,et al.  Automated analysis of polyethylene glycol-induced inhibition of P-glycoprotein activity in vitro. , 2003, Journal of pharmaceutical sciences.

[35]  T. Fujita,et al.  Enhanced Permeability of Insulin across the Rat Intestinal Membrane by Various Absorption Enhancers: Their Intestinal Mucosal Toxicity and Absorption‐enhancing Mechanism of n‐Lauryl‐β‐D‐maltopyranoside , 1999, The Journal of pharmacy and pharmacology.

[36]  L. Benet,et al.  Active secretion and enterocytic drug metabolism barriers to drug absorption 1 PII of original artic , 1996 .

[37]  Y. Lo,et al.  Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats. , 2000, Biochemical pharmacology.

[38]  T. Fujita,et al.  Use of Protease Inhibitors to Improve Calcitonin Absorption from the Small and Large Intestine in Rats , 1998, The Journal of pharmacy and pharmacology.

[39]  K. Audus,et al.  Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers. , 2002, Journal of pharmaceutical sciences.

[40]  J. Cogburn,et al.  A novel in vitro screen to discover agents which increase the absorption of molecules across the intestinal epithelium , 1992 .

[41]  Akira Yamamoto,et al.  Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies. , 2006, International journal of pharmaceutics.

[42]  R. Borchardt,et al.  The Use of Surfactants to Enhance the Permeability of Peptides Through Caco-2 Cells by Inhibition of an Apically Polarized Efflux System , 1996, Pharmaceutical Research.

[43]  L. Benet,et al.  Active secretion and enterocytic drug metabolism barriers to drug absorption. , 2001, Advanced drug delivery reviews.

[44]  Gérard Hopfgartner,et al.  P‐Glycoprotein and Surfactants: Effect on Intestinal Talinolol Absorption , 2005, Clinical pharmacology and therapeutics.

[45]  T. Fujita,et al.  Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs. , 2001, The Journal of pharmacology and experimental therapeutics.

[46]  T. Terasaki,et al.  Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein. , 1993, Biochemical pharmacology.